Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 125

    1.

    Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study.

    Konstas AG, Holló G, Irkec M, Tsironi S, Durukan I, Goldenfeld M, Melamed S.

    Br J Ophthalmol. 2007 Jun;91(6):757-60. Epub 2006 Nov 23.PMID: 17124241 [PubMed - indexed for MEDLINE]Related articles

    2.

    Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.

    Konstas AG, Katsimbris JM, Lallos N, Boukaras GP, Jenkins JN, Stewart WC.

    Ophthalmology. 2005 Feb;112(2):262-6.PMID: 15691561 [PubMed - indexed for MEDLINE]Related articles

    3.

    A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.

    Parrish RK, Palmberg P, Sheu WP; XLT Study Group.

    Am J Ophthalmol. 2003 May;135(5):688-703.PMID: 12719078 [PubMed - indexed for MEDLINE]Related articles

    4.

    A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma.

    Dirks MS, Noecker RJ, Earl M, Roh S, Silverstein SM, Williams RD.

    Adv Ther. 2006 May-Jun;23(3):385-94.PMID: 16912020 [PubMed - indexed for MEDLINE]Related articles

    5.

    Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension.

    Gandolfi S, Simmons ST, Sturm R, Chen K, VanDenburgh AM; Bimatoprost Study Group 3.

    Adv Ther. 2001 May-Jun;18(3):110-21.PMID: 11571823 [PubMed - indexed for MEDLINE]Related articles

    6.

    Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.

    Rossetti L, Karabatsas CH, Topouzis F, Vetrugno M, Centofanti M, Boehm A, Viswanathan A, Vorwerk C, Goldblum D.

    Ophthalmology. 2007 Dec;114(12):2244-51. Epub 2007 Apr 25.PMID: 17459480 [PubMed - indexed for MEDLINE]Related articles

    7.

    A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.

    Noecker RS, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM; Bimatoprost/Latanoprost Study Group.

    Am J Ophthalmol. 2003 Jan;135(1):55-63.PMID: 12504698 [PubMed - indexed for MEDLINE]Related articles

    8.

    A randomised crossover study comparing bimatoprost and latanoprost in subjects with primary angle closure glaucoma.

    How AC, Kumar RS, Chen YM, Su DH, Gao H, Oen FT, Ho CL, Seah SK, Aung T.

    Br J Ophthalmol. 2009 Jun;93(6):782-6. Epub 2009 Mar 30.PMID: 19336424 [PubMed - indexed for MEDLINE]Related articles

    9.

    Efficacy and safety of latanoprost versus travoprost in exfoliative glaucoma patients.

    Konstas AG, Kozobolis VP, Katsimpris IE, Boboridis K, Koukoula S, Jenkins JN, Stewart WC.

    Ophthalmology. 2007 Apr;114(4):653-7. Epub 2006 Dec 29.PMID: 17197028 [PubMed - indexed for MEDLINE]Related articles

    10.

    24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.

    Walters TR, DuBiner HB, Carpenter SP, Khan B, VanDenburgh AM; Bimatoprost Circadian IOP Study Group.

    Surv Ophthalmol. 2004 Mar;49 Suppl 1:S26-35.PMID: 15016559 [PubMed - indexed for MEDLINE]Related articles

    11.

    Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost.

    DuBiner H, Cooke D, Dirks M, Stewart WC, VanDenburgh AM, Felix C.

    Surv Ophthalmol. 2001 May;45 Suppl 4:S353-60.PMID: 11434938 [PubMed - indexed for MEDLINE]Related articles

    12.

    A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure.

    Choplin N, Bernstein P, Batoosingh AL, Whitcup SM; Bimatoprost/Latanoprost Study Group.

    Surv Ophthalmol. 2004 Mar;49 Suppl 1:S19-25.PMID: 15016558 [PubMed - indexed for MEDLINE]Related articles

    13.

    Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma.

    Quaranta L, Pizzolante T, Riva I, Haidich AB, Konstas AG, Stewart WC.

    Br J Ophthalmol. 2008 Sep;92(9):1227-31. Epub 2008 Jun 27.PMID: 18586898 [PubMed - indexed for MEDLINE]Related articles

    14.

    Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.

    Gagliuso DJ, Wang RF, Mittag TW, Podos SM.

    Arch Ophthalmol. 2004 Sep;122(9):1342-7.PMID: 15364714 [PubMed - indexed for MEDLINE]Related articles

    15.

    Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.

    Law SK, Song BJ, Fang E, Caprioli J.

    Ophthalmology. 2005 Dec;112(12):2123-30. Epub 2005 Oct 12.PMID: 16225924 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost.

    Gandolfi SA, Cimino L.

    Ophthalmology. 2003 Mar;110(3):609-14.PMID: 12623831 [PubMed - indexed for MEDLINE]Related articles

    18.

    24-h IOP control with latanoprost, travoprost, and bimatoprost in subjects with exfoliation syndrome and ocular hypertension.

    Hepsen IF, Ozkaya E.

    Eye (Lond). 2007 Apr;21(4):453-8. Epub 2006 Mar 17.PMID: 16543930 [PubMed - indexed for MEDLINE]Related articles

    19.

    A comparison of long-term intraocular pressure fluctuation in patients treated with bimatoprost or latanoprost.

    Simmons ST, Bernstein P, Hollander DA.

    Am J Ophthalmol. 2008 Sep;146(3):473-7. Epub 2008 Jun 17.PMID: 18561893 [PubMed - indexed for MEDLINE]Related articles

    20.

    Comparison of the effects of latanoprost and bimatoprost on intraocular pressure in chronic angle-closure glaucoma.

    Chen MJ, Chen YC, Chou CK, Hsu WM.

    J Ocul Pharmacol Ther. 2007 Dec;23(6):559-66.PMID: 18001247 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data